Tourmaline Bio, Inc. (TRML)

Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)

47.98

0.00 (0.00%)

Inactive · Last trade price on Oct 27, 2025

Tourmaline Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,238	520	532	-	-
Market Cap Growth	75.11%	-2.33%	-	-	-
Enterprise Value	999	238	583	-	-
Last Close Price	-	20.28	26.18	-	-
PB Ratio	4.76	1.73	2.60	-	-
P/TBV Ratio	4.78	1.73	2.60	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.07	-0.66
Quick Ratio	23.70	28.99	40.57	6.06	0.40
Current Ratio	24.68	30.18	41.76	6.10	0.40
Return on Equity (ROE)	-29.62%	-28.99%	-39.66%	-549.77%	-
Return on Assets (ROA)	-20.85%	-21.60%	-25.87%	-266.29%	-
Return on Capital (ROIC)	-21.42%	-22.18%	-26.60%	-314.87%	-
Earnings Yield	-7.15%	-14.08%	-7.91%	-	-
FCF Yield	-6.97%	-14.86%	-5.29%	-	-
Buyback Yield / Dilution	-53.98%	-433.98%	-441.28%	91.94%	-

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q